IS Ⅲ(International Symposium III)
日期:2025年11月08日
地点:海埂会堂 A301+A302
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 13:30-13:45 |
Holistic Approach to Precision Oncology |
AU Siu-Kie | Hong Kong Precision Oncology Society |
| 13:45-14:00 |
Integrative Oncology in Practice: Uruguay’s Pathway Toward Cervical Cancer Elimination |
Kelsy Arbiza | Uruguayan School of Naturopathy |
| 14:00-14:15 |
Implementation of Digital Pathology in Precision Oncology in Bulgaria |
Zhasmina Balabanova | Bulgarian Alliance for Precision and Personalized Medicine |
| 14:15-14:30 |
The medical responsibility in the use of AI for holistic cancer care |
Naoufal Louati | Morocco TCM Institute |
| 14:30-14:50 |
Panel Discussion |
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 14:50-15:05 |
Cancer Liquid Biopsy: Perspectives & Challenges |
Mengsu Yang | City University of Hong Kong |
| 15:05-15:20 |
Updates in axillary surgery in era of neoadjvant therapy |
Gamal Amira | National cancer institute cairo university |
| 15:20-15:35 |
Real-World Experience with Immunotherapy in Melanoma: Clinical Insights and Outcomes |
Dejan Djokanovic | University Clinical Center of the Republic of Srpska |
| 15:35-15:50 |
Assessment of Body composition and importance of muscle mass during cancer treatment |
Vanessa Fuchs Tarlovsky | Hospital General de Mexico |
| 15:50-16:10 |
Panel Discussion |
||
| 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|
| 16:10-16:25 |
Expanding Cancer Care in the Elderly |
Derek A. O Reilly | Beijing United Family Hospital |
| 16:25-16:40 |
Psychosocial, educational, and symptom management patient support services at the Institute for Oncology and Radiology of Serbia |
Ana Jovicevic | Institute for Oncology and Radiology of Serbia |
| 16:40-16:55 |
Growth of Integrative Oncology for better treatment outcomes in patients with Cancer |
Rose Fok Wai Yee | National Cancer Centre Singapore |
| 16:55-17:10 |
Traditional Chinese Medicine in the Czech Republic |
Jitka Lidarikova | Czech Traditional Chinese Medicine Centre |
| 17:10-17:30 |
Panel Discussion & Closing Remarks |
||